These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25622927)

  • 1. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.
    Sumida Y; Kanemasa K; Imai S; Mori K; Tanaka S; Shimokobe H; Kitamura Y; Fukumoto K; Kakutani A; Ohno T; Taketani H; Seko Y; Ishiba H; Hara T; Okajima A; Yamaguchi K; Moriguchi M; Mitsuyoshi H; Yasui K; Minami M; Itoh Y
    J Gastroenterol; 2015 Sep; 50(9):996-1004. PubMed ID: 25622927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Papatheodorou A; Patsiaoura K; Katsiki E; Zafeiriadou E; Zavos C; Anastasiadou K; Terpos E
    Metabolism; 2013 Jan; 62(1):121-6. PubMed ID: 22841522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.
    Baeg MK; Yoon SK; Ko SH; Noh YS; Lee IS; Choi MG
    World J Gastroenterol; 2016 Feb; 22(8):2592-600. PubMed ID: 26937147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study.
    Polyzos SA; Nikolopoulos P; Stogianni A; Romiopoulos I; Katsinelos P; Kountouras J
    Arq Gastroenterol; 2014; 51(3):261-8. PubMed ID: 25296089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between endotoxemia and histological features of nonalcoholic fatty liver disease.
    Kitabatake H; Tanaka N; Fujimori N; Komatsu M; Okubo A; Kakegawa K; Kimura T; Sugiura A; Yamazaki T; Shibata S; Ichikawa Y; Joshita S; Umemura T; Matsumoto A; Koinuma M; Sano K; Aoyama T; Tanaka E
    World J Gastroenterol; 2017 Jan; 23(4):712-722. PubMed ID: 28216979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
    Kim TJ; Sinn DH; Min YW; Son HJ; Kim JJ; Chang Y; Baek SY; Ahn SH; Lee H; Ryu S
    J Gastroenterol; 2017 Nov; 52(11):1201-1210. PubMed ID: 28382402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum homocysteine levels in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Patsiaoura K; Katsiki E; Zafeiriadou E; Deretzi G; Zavos C; Gavalas E; Katsinelos P; Mane V; Slavakis A
    Ann Hepatol; 2012; 11(1):68-76. PubMed ID: 22166563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance between Helicobacter
    Mohammadifard M; Saremi Z; Rastgoo M; Akbari E
    J Med Life; 2019; 12(2):168-172. PubMed ID: 31406519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The associations among Helicobacter pylori infection, white blood cell count and nonalcoholic fatty liver disease in a large Chinese population.
    Yu YY; Cai JT; Song ZY; Tong YL; Wang JH
    Medicine (Baltimore); 2018 Nov; 97(46):e13271. PubMed ID: 30431613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease.
    Tang DM; Kumar S
    Curr Gastroenterol Rep; 2017 Feb; 19(2):5. PubMed ID: 28155087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Helicobacter pylori seropositivity and mild to moderate COPD: clinical implications in an Asian country with a high prevalence of H. pylori.
    Lee HY; Kim JW; Lee JK; Heo EY; Chung HS; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2055-62. PubMed ID: 27621611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.
    Kamada Y; Akita M; Takeda Y; Yamada S; Fujii H; Sawai Y; Doi Y; Asazawa H; Nakayama K; Mizutani K; Fujii H; Yakushijin T; Miyazaki M; Ezaki H; Hiramatsu N; Yoshida Y; Kiso S; Imai Y; Kawada N; Takehara T; Miyoshi E
    PLoS One; 2013; 8(6):e66328. PubMed ID: 23805214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States.
    Kang SJ; Kim HJ; Kim D; Ahmed A
    PLoS One; 2018; 13(8):e0202325. PubMed ID: 30110395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma?
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; Elhelaly R; Elzehery R; Abdelsalam M; Elgamal A; Nassar MR; Abu El-Soud A; Seif AS; Tawfik AM; El-Wakeel N; Eldars W
    Helicobacter; 2018 Dec; 23(6):e12537. PubMed ID: 30246507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
    McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
    J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency and long persistency of ballooning hepatocyte were associated with glucose intolerance in patients with severe obesity.
    Kakisaka K; Sasaki A; Umemura A; Nikai H; Suzuki Y; Nishiya M; Sugai T; Nitta H; Takikawa Y
    Sci Rep; 2021 Jul; 11(1):15392. PubMed ID: 34321567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver fibrosis markers of nonalcoholic steatohepatitis.
    Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
    World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease.
    Kakisaka K; Suzuki Y; Fujiwara Y; Abe T; Yonezawa M; Kuroda H; Ishida K; Sugai T; Takikawa Y
    J Gastroenterol; 2018 Dec; 53(12):1285-1291. PubMed ID: 29680867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.